Wayne Weisman, Director at Recro Pharma, Inc. (REPH), sold 14,992 shares at $6.45 ($97K) on 2016-05-20, disclosed to the SEC on 2016-05-23.
Open-market sale of $97k REPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RWLK | SELL | 2016-08-17 | $282K | — | Filing → |
| RWLK | SELL | 2016-06-06 | $109K | — | Filing → |
| RWLK | SELL | 2016-05-27 | $235K | — | Filing → |